Factors associated with late risks of breast cancer-specific mortality in the SEER registry
José P Leone, Carlos T Vallejo, Michael J Hassett, Julieta Leone, Noah Graham, Nabihah Tayob, Rachel A Freedman, Sara M Tolaney, Bernardo A Leone, Eric P Winer, Nancy U Lin.
Tumor subtypes and survival in male breast cancer
Julieta Leone, Rachel A Freedman , Nancy U Lin, Sara M Tolaney, Carlos T Vallejo, Bernardo A Leone, Eric P Winer, José Pablo Leone.
Twenty-year risks of breast cancer-specific mortality for stage III breast cancer in the surveillance, epidemiology, and end results registry
José P Leone, Bernardo A Leone, Nabihah Tayob, Michael J Hassett, Julieta Leone, Rachel A Freedman, Sara M Tolaney, Eric P Winer, Carlos T Vallejo, Nancy U Lin.
The prognostic significance of metastatic pattern in stage IV male breast cancer at initial diagnosis: a population-based study
José Pablo Leone, Bernardo Amadeo Leone, Ariel O Zwenger, Carlos Teodoro Vallejo, Alberto Omar Romero, Mario Raúl Machiavelli, Juan Eduardo Pérez, Julieta Leone.
Prognostic Significance of Tumor Subtypes in Women With Breast Cancer According to Stage: A Population-based Study
José P Leone , Julieta Leone , Ariel O Zwenger , Carlos T Vallejo , Bernardo A Leone.
Overall Survival of Men and Women With Breast Cancer According to Tumor Subtype: A Population-based Study
Julieta Leone, Ariel O Zwenger, Bernardo A Leone, Carlos T Vallejo, José P Leone.
Locoregional treatment and overall survival of men with T1a,b,cN0M0 breast cancer: A population-based study.
Leone JP, Leone J, Zwenger AO, Iturbe J, Leone BA, Vallejo CT.
Prognostic factors and survival according to tumour subtype in women presenting with breast cancer brain metastases at initial diagnosis.
Leone JP, Leone J, Zwenger AO, Iturbe J, Leone BA, Vallejo CT.
Male Breast Cancer: A Single-Institution Clinicopathologic and Immunohistochemical Study
Serdy KM, Leone JP, Dabbs DJ, Bhargava R
Breast cancer is a systemic disease rather than an anatomical process
Leone B, Leone J, Leone JP
Dabigatran-related leukocytoclastic vasculitis
An J, Garje R, Wanat AK, Leone JP
Prognostic impact of metastatic pattern in stage IV breast cancer at initial diagnosis
Leone B, Vallejo CT, Romero AO, Machiavelli M, Perez JE, Leone J, Leone JP
Adjuvant systemic therapy in older women with breast cancer
Leone J, Leone B, Leone JP
Gemcitabine Induced Cutaneous Collagenous Vasculopathy in a Breast Cancer Patient
Leone JP
Sensitive detection of mono- and polyclonal ESR1 mutations in primary tumors, metastatic lesions and cell free DNA of breast cancer patients.
Wang P, Bahreini A, Gyanchandani R, Lucas P, Hartmaier RJ, Watters RJ, Jonnalagadda AR, Trejo Bittar HE, Berg A, Hamilton RL, Kurland BF, Weiss K, Mathew A, Leone JP, Davidson NE, Nikiforova MN, Brufsky AM, Ambros TF, Stern AM, Puhalla S, Lee AW, Oesterreich S.
Metastatic Adenoid Cystic Carcinoma of the Breast.
Monga V, Leone JP.
Prognostic factors in male breast cancer: a population-based study.
Leone JP, Zwenger AO, Iturbe J, Leone J, Leone BA, Vallejo CT, Bhargava R.
Locoregional treatment (LRT) and overall survival (OS) of men with T1a,b,cN0M0 breast cancer: a population-based study.
Jose Pablo Leone, Julieta Leone, Ariel Osvaldo Zwenger, Julian Iturbe, Bernardo Amadeo Leone, Carlos Teodoro Vallejo.
Breast Cancer Risk and Prognostic Factors in Two Argentine Settings
Sandra O. Demichelis, Luciano Cermignani, Ariel Zwenger, Nora Giacomi, Alberto Barbera, Amada Segal-Eiras and Maria Virginia Croce.
Relevant Role of Di-Fucosylated Ley Antigen in the Outcome of Locally Advanced Cervical Squamous Cell Carcinoma Patients Treated with Cisplatin Regimen
Leone J, Perez JE, Dominguez ME, Iturbe J, Leone JP, Mac Donnell MC, Grosman G, Vallejo CT, Leone BA and Zwenger AO.
Prognostic Significance of Tumor Subtypes in Male Breast Cancer: a Population-Based Study.
José Pablo Leone; Julieta Leone; Ariel Osvaldo Zwenger; Julián Iturbe; Carlos Teodoro Vallejo; Bernardo Amadeo Leone. Breast Cancer Res Treat. 2015 Aug;152(3):601-9. doi: 10.1007/s10549-015-3488-y. Epub 2015 Jul 1
Expression of ERCC1 and TUBB3 in locally advanced squamous cervical cancer and its correlation with different therapeutic regimens.
Ariel O. Zwenger, Gabriel Grosman, Julian Iturbe, Julieta Leone, Carlos T. Vallejo, MD, José P. Leone, Palmira Pérez Verdera, Juan E. Pérez, Bernardo A. Leone. Int J Biol Markers, 2015 Jul 22;30(3):e301-14-doi: 10.5301/jbm.5000161
From molecular biology to clinical trials. Towards a personalized colorectal cancer therapy.
Sabina Palma, Ariel O. Zwenger, María V. Croce, Martín C. Abba, Ezequiel Lacunza. Clinical Colorectal Cancer · November 2015. DOI: 10.1016/j.clcc.2015.11.001
Breast cancer brain metastases: the last frontier.
Leone JP, Leone BA. Exp Hematol Oncol. 2015 Nov 24;4:33. DOI 10.1186/s40164-015-0028-8
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Dowsett M, Forbes JF, Bradley R, Ingle J, Aihara T, Bliss J, Boccardo F, Coates A, Coombes RC, Cuzick J, Dubsky P, Gnant M, Kaufmann M, Kilburn L, Perrone F, Rea D, Thürlimann B, van de Velde C, Pan H, Peto R, Davies C, Gray R and collaborators (764). Lancet. 2015 Oct 3;386(10001):1341-52. doi: 10.1016/S0140-6736(15)61074-1. Epub 2015 Jul 23.
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Coleman R, Powles T, Paterson A, Gnant M, Anderson S, Diel I, Gralow J, von Minckwitz G, Moebus V, Bergh J, Pritchard KI, Bliss J, Cameron D, Evans V, Pan H, Peto R, Bradley R, Gray R and collaborators (728). Lancet. 2015 Oct 3;386(10001):1353-61. doi: 10.1016/S0140-6736(15)60908-4. Epub 2015 Jul 23.
Prognostic factors in male breast cancer: A population-based study.
Leone JP, Zwenger AO, Iturbe J, Leone J, Leone BA, Vallejo CT and Bhargava R.
Effect of probiotics on survival in a rat colorectal cancer model treated with capecitabine.
G. Gigola, A. Zwenger, H. V. Maturi, G. Perdigón. Ann Oncol (2014) 25 (suppl 4):iv54. doi: 10.1093/annonc/mdu325.5
Role of CD44 and Lewis Y antigen in chemoresistance of locally advanced cervical squamous cell carcinoma (LACSCC) patients.
J. Leone; J.E. Perez; M.E. Dominguez; J. Iturbe; J.P. Leone; M.C. Mac Donnell; G. Grosman; C.T. Vallejo; B.A. Leone; A.O. Zwenger. J Clin Oncol 33, 2015 (suppl; abstr e16590). 2014
Características clínicas y patológicas del cáncer de mama triple negativo y su comparación con los otros subtipos en pacientes del Hospital Provincial Neuquén
S. Morales, A. Novoa, L. Gil, S. Bernardi, M. Mac Donnel, A. Zwenger. Rev. Arg de Mastologia 2014,33(119):127-137
High expression of sLex associated with poor survival in Argentine colorectal cancer patients
A. O. Zwenger, M.E. Rabassa, S. Demicelis, G. Grossman, A. Segal-Eiras, M.V. Croce. Int J Biol Markers. 2014 Mar 24;29(1):e30-9. doi: 10.5301/jbm.5000060.
Breast cancer cutaneous metastases: implications of MUC1 and carbohydrate associated antigens in tumor dissemination.
Luna AM, Merino ME, Alberdi CG, Cabaleiro P, Zwenger A, Segal-Eiras A, Croce MV. 55th Annual Meeting of the Italian Cancer Society., At Catanzaro, Italia.
A prospective study of ERCC1 protein expression and gene polymorphisms in locally advanced cervical squamous cell carcinoma patients treated with cisplatin-based concurrent chemoradiotherapy.
A. Álvarez A. Zwenger, G. Marechal, S. Acevedo, S. Audero, N. Krause, A. Cuevas, A. Yanzi, X. García, M. Pallotta. European Journal of Cancer, Volume 49 Supplement 2, September 2013.
Analysis of prognostic factors after 16 years of follow-up in a randomized phase II trial of neoadjuvant FAC compared with CMF in stage III breast cancer.
Julieta Leone, Jose Pablo Leone, Carlos Teodoro Vallejo, Juan Eduardo Perez, Alberto Omar Romero, Mario Raul Machiavelli, Luis Romero Acuna, Maria Ester Dominguez, Mario Langui, Hebe Margot Fasce, Bernardo Amadeo Leone, Eduardo Ortiz, Julian Iturbe, Ariel Osvaldo Zwenger; J Clin Oncol 31, 2013 (suppl; abstr 11118)
Importance of socioeconomic status in relation to breast cancer risk and prognostic factors in Argentina.
MV Croce, SO Demichelis, L Cermignani, A Zwenger, A Segal-Eiras, N Giacomi. Cancer Res 2012;72(24 Suppl).
Differential antigenic expression in colorectal cancer, mucosa adjacent to colorectal cancer, and normal colorectal mucosa.
A. Zwenger, G. Grosman, S. Demichellis, A. Segal-Eiras, M.V. Croce. ESMO, September 28, 2012. Abstrac #619.
Prognostic relevance of partial hormone receptor expression in stage I breast cancer.
Ariel Zwenger, Julieta Leone, Julian Iturbe, Palmira Perez Verdera, Jose Pablo Leone, Bernardo Amadeo Leone, Carlos Teodoro Vallejo. J Clin Oncol 30, 2012 (suppl; abstr e11021)
Sixteen years follow-up results of a randomized phase II trial of neoadjuvant fluorouracil, doxorubicin, and cyclophosphamide (FAC) compared with cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in stage III breast cancer: GOCS experience.
Leone JP, Leone J, Vallejo CT, Pérez JE, Romero AO, Machiavelli MR, Romero Acuña L, Domínguez ME, Langui M, Fasce HM, Leone BA, Ortiz E, Iturbe J, Zwenger AO. Breast Cancer Res Treat. 2014 Jan;143(2):313-23. doi: 10.1007/s10549-013-2806-5. Epub 2013 Dec 11.
RHBDD2: a 5-fluorouracil responsive gene overexpressed in the advanced stages of colorectal cancer.
Ezequiel Lacunza, R. Canzoneri, M. E. Rabassa, A. Zwenger, A. Segal-Eiras, M. V. Croce & M. C. Abba. Tumor Biol. 2012 Dec;33 (6):2393-9. doi: 10.1007/s13277-012-0503-3. Epub 2012 Sep 11.
Treatment of Early Breast Cancer, a Long-term Follow-up Study: The GOCS Experience.
Julián Iturbe, Ariel Zwenger, José Pablo Leone, Palmira Perez Verdera, Carlos Vallejo, Alberto Romero, Juán Perez, Mario Machiavelli, Bernardo Leone. Breast J. 2011 Nov-Dec;17(6):630-7.
Comparación de dos protocolos de inducción de cáncer colorrectal en ratas wistar lewis con 1,2-dimetilhidrazina
Gígola Graciela, Melatini Gabriel, Ullua Natalia, Cardozo Clara, Martín Arrieta Gonzalo, Pérez Juan Eduardo. Oncología Clínica, Órgano de la Asociación Argentina de Oncología Clínica, Vol. 16, Nº 1, 2011.
Neoadjuvant endocrine treatment of women with breast cancer
Julian Iturbe, Ariel Zwenger, Carlos Vallejo, Bernardo Leone, Pablo Leone. Oncology Review. Vol 5, No 3 (2011)
Relationship among antigenic markers, disease progression, and survival in colorectal cancer (CCR) patients.
A. Zwenger, M. V. Croce, A. Segal-Eiras, M. Rabassa, J. Iturbe, C. T. Vallejo, B. A. Leone, G. Grosman. J Clin Oncol 28, 2010 (suppl; abstr e14060).
Morphologic features associated with mucin and carbohydrate antigens in colorectal cancer (CCR).
M. V. Croce, A. Zwenger Sr., A. Segal-Eiras, M. Rabassa, J. Iturbe, G. Grosman, B. A. Leone, C. T. Vallejo. J Clin Oncol 28, 2010 (suppl; abstr e14129).
Intracellular distribution of p300 and its differential recruitment to aggresomes in breast cancer
María E. Fermento, Norberto A. Gandini, Cecilia A. Lang, Juan E. Pérez, Horacio V. Maturi, Alejandro C. Curino, María M. Facchinetti. Experimental and Molecular Pathology, 88, Issue 2, April 2010, 256–264.
Metastasis of breast carcinoma to spinal meningioma
Leone José Pablo, Cabaleiro Patricia, Iturbe Julián, Zwenger Ariel, Scuteri Roberto, Castro Jorge, Lacava Juan, Vallejo Carlos, Leone Bernardo. The Breast Journal. Vol 15, Issue 5, start page 539, 2009.
Mucins and carbohydrates associated antigens expression in colorectal cancer patients.
A. O. Zwenger, Sr., C. Andrea, E. Lacunza, M. Rabassa, S. Amada, M. V. Croce, J. Iturbe, P. Leone, J. A. Lacava and M. R. Machiavelli. J Clin Oncol 26: 2008 (May 20 suppl; abstr 15072)
Prognostic factors in metastatic colorectal carcinoma at initial diagnosis, MCCID.
C. T. Vallejo, A. O. Zwenger, J. A. Lacava, J. Iturbe, J. E. Perez, M. Machiavelli, A. Romero, M. E. Dominguez, R. Rodriguez and B. Leone. Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S (June 20 Supplement), 2007: 14548
The impact of metastatic sites in metastatic colorectal cancer at initial diagnosis (MCCID).
B. A. Leone, J. A. Lacava, A. O. Zwenger, J. Iturbe, J. E. Perez, M. R. Machiavelli, A. O. Romero, C. T. Vallejo, M. E. Dominguez and R. Rodriguez. Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S (June 20 Supplement), 2007: 14536